glp 1 agonist binge eating disorder The rapid rise of GLP-1 receptor agonists presents a complex dilemma for clinicians managing patients with disorders. While these medications show potential in reducing eating behaviors by targeting brain reward Does GLP-1 Help with Binge

These claims often involve extensive review of medical records, autopsy findings, hospitalization history, prescription records, and expert medical opinions regarding causation

Tirzepatide has a comparable safety profile to GLP-1RA (54, 70)

To manage symptoms effectively: Start with a low dose and titrate slowly Encourage smaller, low-fat meals Consider changing the dosing schedule or formulation Evaluate other GI causes like gastroparesis if symptoms linger Having regular check-ins helps clinicians identify tolerability issues early and adapt treatment accordingly

( 10.1111/bph.13009) [DOI] [PMC free article] [PubMed] [Google Scholar] Scott RA, Freitag DF, Li L, Chu AY, Surendran P, Young R, Grarup N, Stancakova A, Chen Y, Varga TV, et al

They do appear to be a reasonable second-line add-on therapy to metformin, especially in individuals at high risk for hypoglycemia (i.e